US20150290396A1 - Drug dispensing-tracking device, system and method - Google Patents

Drug dispensing-tracking device, system and method Download PDF

Info

Publication number
US20150290396A1
US20150290396A1 US14/438,177 US201314438177A US2015290396A1 US 20150290396 A1 US20150290396 A1 US 20150290396A1 US 201314438177 A US201314438177 A US 201314438177A US 2015290396 A1 US2015290396 A1 US 2015290396A1
Authority
US
United States
Prior art keywords
injection device
drug
injection
sensor
signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/438,177
Other languages
English (en)
Inventor
Ron Nagar
Gabriel Bitton
Moshe Fadlun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insuline Medical Ltd
Original Assignee
Insuline Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insuline Medical Ltd filed Critical Insuline Medical Ltd
Priority to US14/438,177 priority Critical patent/US20150290396A1/en
Publication of US20150290396A1 publication Critical patent/US20150290396A1/en
Assigned to INSULINE MEDICAL LTD. reassignment INSULINE MEDICAL LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FADLUN, Moshe, NAGAR, RON, BITTON, GABRIEL
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202—Devices for protection of the needle before use, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/02—Burettes; Pipettes
    • B01L3/0289—Apparatus for withdrawing or distributing predetermined quantities of fluid
    • B01L3/0293—Apparatus for withdrawing or distributing predetermined quantities of fluid for liquids
    • G—PHYSICS
    • G08—SIGNALLING
    • G08B—SIGNALLING OR CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS
    • G08B3/00—Audible signalling systems; Audible personal calling systems
    • G08B3/10—Audible signalling systems; Audible personal calling systems using electric transmission; using electromagnetic transmission
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3306—Optical measuring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3327—Measuring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/08—Ergonomic or safety aspects of handling devices
    • B01L2200/087—Ergonomic aspects
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/02—Identification, exchange or storage of information
    • B01L2300/021—Identification, e.g. bar codes
    • B01L2300/022—Transponder chips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/02—Identification, exchange or storage of information
    • B01L2300/023—Sending and receiving of information, e.g. using bluetooth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0672—Integrated piercing tool

Definitions

  • Embodiments of the present disclosure generally relate to drug dispensers and particularly to drug dispensing, injecting and tracking devices, systems and corresponding methods thereof.
  • Various illnesses and disorders require multiple injections to control or treat a physiological condition.
  • insulin dependent diabetics are required to inject several injections of insulin, of one or more types, each day to control their blood sugar levels.
  • diabetics are required to log each injection in a log book and report the injections, as well as their blood sugar levels, at the time of injections to their physician on each visit to the physician.
  • the data records may be used by the physician to administrate further course of treatment. Therefore proper data recording is important to achieve improvement in treatment.
  • Patients, such as diabetics, during the course of their daily treatment may use more than one injection device, disposable or reusable, to inject insulin, of the same or different type while they usually use a single blood glucose meter to measure their blood glucose levels during that time.
  • Some blood glucose meters today are capable of logging each measurement or even real time wireless transmission of the measurement to a central database (like the TELCARE® blood glucose meter: http://telcare.com/), and there also are injection devices (e.g., injection pens) that have integrated logging functionality (e.g., amount of injected drug, time of injection, and date, such as the PENDIQ® device http://www.pendiq.com).
  • injection devices e.g., injection pens
  • integrated logging functionality e.g., amount of injected drug, time of injection, and date, such as the PENDIQ® device http://www.pendiq.com.
  • the tracking device may be formed of or with a sleeve or housing configured to, for example, slide or otherwise be affixed on and/or off an injection device (the terms “sleeve” and “body” can be used interchangeably throughout the present disclosure).
  • the sleeve can be configured to fit mechanical features on the body of the injection device so as to prevent it from detaching from the injection device or otherwise uniquely fit to a certain injection device with a specific drug.
  • the body of the device can include at least one of a battery, a sensor that can be, for example, at least one microphone, electrical circuit, a transmission element such as a transponder and optionally, a switch, A/D converter, processor, unique identifier and memory.
  • the microphone may be activated with each injection, capturing (for example), the sound and vibration created when the user sets the injection device to inject the desired amount of drug.
  • the microphone may also capture sounds at the time when the drug is injected (such sound information may be stored on the device with provided memory or otherwise immediately wirelessly transmitted to another unit for analysis).
  • This information may be transmitted to a unit which can capture the signal, analyze it to get the data on the amount of drug that was just injected, or if the device has a memory, a processor and a unique identifier, the processor can analyze the sound information to get the information on the amount of drug that was injected, store it in the memory and transmit it to a receiving central unit (e.g. an external unit and/or central database) along with the unique identification information.
  • a receiving central unit e.g. an external unit and/or central database
  • the sleeve may be arranged on any injector devices of a user. Afterwards, each injection made by those injector devices can then be wirelessly transmitted to a central unit (which may be immediately after injection, or at a later time). The data transmitted to the central unit can be logged for later download to a central database, or if the central unit has cellular wireless transmission capabilities (for example, or other wireless transmission functionality), the data may be transferred in real time to a central database.
  • a central unit which may be immediately after injection, or at a later time.
  • the data transmitted to the central unit can be logged for later download to a central database, or if the central unit has cellular wireless transmission capabilities (for example, or other wireless transmission functionality), the data may be transferred in real time to a central database.
  • Such a central unit can be any of, for example: a blood glucose meter, and a device worn on the skin of the user which may also be used to improve the kinetics of the injected drug like the INSUPAD® device of Insuline-Medical (insuline-medical.com), a cellular phone, and any other device which can be in wireless communication with each of the sleeves.
  • a blood glucose meter and a device worn on the skin of the user which may also be used to improve the kinetics of the injected drug like the INSUPAD® device of Insuline-Medical (insuline-medical.com), a cellular phone, and any other device which can be in wireless communication with each of the sleeves.
  • the sleeve may include a switch that can be toggled between two or more states by the user, including, for example, turning the injection device on, directional indication for indicating the direction of an injection device rotation to set the amount of the injected drug and/or correction of a mistake made by the user in the amount to be injected.
  • the sleeve may also include an element (e.g., sensor) for automatic detection of an injection event that is monitored by a processor (e.g., of the sleeve) to sense when an injection event is to be performed.
  • Such an injection event sensor may be realized by communication between the sleeve electronics of embodiments according to the present disclosure and the electronics of a blood glucose meter and/or the electronics of a device like INSUPAD, to sense when a blood glucose measurement was taken, or when the INSUPAD (for example) was activated. Since such events come before an injection, they can be used to signal the electronics that an injection is about to be performed, and thus, the capturing electronics of the sleeve may be activated.
  • another way to realize automatic activation of the sleeve electronics can be based on removing the protective cap found on the injection device, as most injection devices include a protective cap that is removed before injection is made.
  • removing the protective cap of the injection device can be used to switch “on” the electronics of the sleeve (e.g., in some embodiments, the vibrations/noise produced when removing the cap and switch on the electronics, and/or an actual switch configured to interact with the cap can be provided on the sleeve).
  • One or more sensors provided with the sleeve can be, for example, at least one of or any combination of a sound sensor and a vibration sensor.
  • a sound sensor can be surrounded by or mounted in a vibration isolation material which isolates the vibration and is sensitive to the sound signal.
  • algorithms can be implemented that use a signal from one or more sensors to improve the detection and immunity to noise.
  • a drug dispensing-tracking device for use in combination with a drug-injection device, where the device comprises a sleeve configured to connect with at least one mechanical feature provided on the injection device, a battery, at least one sensor, an electrical circuit for analog or digital short range communication, and a transmission element.
  • the sensor for each injection, is configured to automatically detect at least one of an auditory signal, movement, and optical signal, and an auditory signal is generated by at least one of the setting of the injection device for dispensing a drug, the dispensing action of the injection device, and the flow of the drug out of the injection device.
  • a method for tracking dispensing of a drug from an injection device comprises providing a dispensing tracking device, the device comprising a sleeve configured to connect with at least one mechanical feature provided on the injection device, a battery, at least one sensor, and detecting at least one of an auditory signal, movement, and an optical signal generated by at least one of the setting of the injection device for dispensing a drug, the dispensing action of the injection device, and the flow of the drug out of the injection device.
  • a system for injecting and tracking a drug comprising a device for tracking the dispensing of a drug injected by an injection device and an external unit.
  • the device comprises a sleeve configured to connect with at least one mechanical feature provided on the injection device, a battery, at least one sensor, a transmission element, a processor, and a memory.
  • the sensor is configured to automatically detect at least one of an auditory signal, movement, and optical signal generated by at least one of the setting of the injection device for dispensing a drug, the dispensing action of the injection device, and the flow of the drug out of the injection device.
  • the external unit may also include a memory.
  • the sensor generates a second signal in response to the detected signal, the processor converts the second signal to data, and/or the data is wirelessly transmitted via the transmission element to the external unit.
  • One and/or another of tracking device embodiments disclosed in the present disclosure may additionally include one or more of the following features:
  • FIG. 1 is a schematic illustration of an exemplary drug dispensing-tracking system according to some embodiments of the present disclosure
  • FIG. 2 is an exploded view of the drug dispensing-tracking system of FIG. 1 ;
  • FIG. 4 is a schematic illustration of a drug dispensing-tracking device shown in FIG. 1 ;
  • FIGS. 6A , 6 B and 6 C are schematic illustrations of an exemplary drug dispensing-tracking system according to some embodiments of the present disclosure, at a disassembled state ( 6 A), at a first assembled operational state ( 6 B) and at a second assembled operational state ( 6 C), respectively;
  • FIG. 7 is a schematic illustration of a drug dispensing-tracking device shown in FIGS. 6A-6C ;
  • FIG. 8 is a schematic illustration of an exemplary drug dispensing-tracking system according to some embodiments of the present disclosure.
  • FIG. 9 is a graph illustrating a method for tracking dispensing of a drug from an injection device according to some embodiments of the present disclosure.
  • FIGS. 1-4 are illustrations of an exemplary drug dispensing-tracking system 100 according to some embodiments of the present disclosures.
  • the drug dispensing-tracking system 100 may comprise a drug dispensing-tracking device 102 used in combination with a drug-injection device 106 (or a pen injector).
  • the injection device 106 configured for injection of a drug in a user, such as a patient, may comprise a shaft 108 .
  • the shaft 108 may be formed with a drug reservoir 110 containing a drug to be injected via a needle 114 .
  • the drug may be injected by pressing a button 116 which urges dispensing of the drug from the drug reservoir 110 into the needle 114 .
  • a desired amount of injected drug may be determined by rotating a rotation knob 120 .
  • the rotation knob 120 may comprise a plurality of notches 122 or any other indicator.
  • the rotation of the notch 122 to a first direction is performed to set the amount of drug to be dispensed from the drug reservoir 110 , before the drug is injected.
  • the rotation of the notch 122 to a second, opposite direction is performed to correct, if necessary, the amount of drug to be dispensed from the drug reservoir 110 .
  • a patient may determine the desired amount of injected drug by the number of notches rotated.
  • the rotation of the knob 120 at the first or second directions may be accompanied by a clicking sound. These sounds (created by rotating the knob 120 to first or second directions) may be different when properly analyzed, as illustrated in FIG. 9 .
  • the predetermined amount of the drug released by the rotation of a notch 122 may be different in different injection devices 106 .
  • the type of drug may be different in different injection devices 106 .
  • the injection device 106 is configured for limited or even single use. Accordingly, a patient may routinely use more than one drug-injection devices 106 during the course of his daily treatment.
  • a display window 126 may shows the amount of injected drug.
  • the injection device 106 may include a rotating element, such as a cap 130 , which may be attached thereto in any suitable manner, such as by a snap attachment (for example).
  • the tracking device 102 may be provided for tracking the injection of the drug and may comprise a base formed as a sleeve 134 .
  • the sleeve 134 may be configured to connect with a mechanical feature of the injection device 106 , removably or non-removably (i.e., permanently).
  • the tracking device may comprise a housing with one or more clamps (or clamp-like elements), for affixing (either permanently or non-permanently) to an injection device.
  • the sleeve 134 may be configured for removable or permanent connection with a mechanical feature or shape of the injection device 106 , such that the shaft movement during an injection is not affected, and ease of use and accuracy of the injection device 106 may be maintained.
  • injection device 106 may be configured with the mechanical feature, which may comprise, for example, any structural feature, or the shape of the injection device or a feature thereof.
  • the structural feature may include a topographical feature on an external surface 135 ( FIG. 6A ) of the injection device 106 .
  • the topographical feature may comprise for example, a protrusion, a dent, a notch, a recess or an aperture and may be formed in any location of the injection device 106 .
  • the sleeve 134 may be formed with a mechanical feature configured to correspond with the mechanical feature of the injection device 106 . In a non-limiting example as seen in FIG.
  • the injection device 106 may be formed with a circumferential recess 136 in proximity to the interface between the cap 130 and shaft 108 .
  • the sleeve 134 may be formed with a corresponding circumferential protrusion 137 and may fit within the circumferential recess 136 .
  • the mechanical feature of the injection device 106 may comprise any feature allowing the sleeve to connect thereto.
  • the mechanical feature may comprise a relevant dimension, such as a predetermined circumference.
  • the sleeve may be formed with a corresponding circumference for fitting to the injection device 106 .
  • a sleeve 134 may be formed with mechanical features corresponding to the unique mechanical features of a selected commercial injection device and may be non-interchangeable with another sleeve formed with mechanical features corresponding to the unique mechanical features of another selected commercial injection device. Accordingly, each sleeve may be identified by its mechanical features and may be associated with a selected commercial injection device.
  • Each type of a commercial injection device 106 may be configured to inject a specific type of drug and a specific dose. Therefore, in identifying the corresponding sleeve, the specific type of drug and a specific dose may also be identified.
  • the sleeve 134 may comprise a longitudinal perforation or opening 138 along a longitudinal axis 139 on at least a portion thereof.
  • the sleeve 134 may be mounted on the tracking device 102 by opening the sleeve 134 at its perforation 138 ( FIG. 6A ), placing the injection device 106 within the sleeve 134 and closing the sleeve 134 over the injection device 106 ( FIG. 6B ).
  • the sleeve 134 may be formed with an attachment feature for connecting to the injection device 106 , such as a threaded attachment, an O-ring, a cord or a sealant or any other attachment feature securing the tracking device 102 to the injection device 106 .
  • the tracking device 102 may comprise a sensor 140 , or an array of sensors, of the same or different types or any combination of sensors, configured to detect a signal indicating an activity performed by the injection device 106 .
  • the activity performed by the injection device 106 may be, yet not limited to, any one of setting the injection device 106 for dispensing the drug, the dispensing action of the injection device 106 or the flow of the drug into a user.
  • the signal may be an auditory signal generated by an activity performed by the injection device 106 .
  • the sensor 140 may comprise a microphone for detecting the auditory signal, such as the clicking sound generated at the rotation of the knob 120 and/or the pressing of the button 116 .
  • auditory signals may include any vibration generated by setting and/or using the injection device.
  • the microphone may comprise any suitable configuration such as an analog device including an ADMP504, ADMP521 or ADMP441-I2S.
  • the number of clicks detected by the microphone may indicate the amount of drug injected by the user. Additionally, the microphone may detect different distinguishable sounds indicating the direction of the rotation of the knob 120 , which as described, may correspond to addition or removal of the drug for injection thereof.
  • a plurality of microphones 144 may be provided and may be arranged around a periphery of the sleeve 134 , as shown in FIG. 4 or at any other location.
  • the auditory signal detected by the microphones 144 may indicate the rotation direction of the knob 120 .
  • the signal may be a vibration signal generated by an activity performed by the injection device 106 .
  • the sensor 140 may comprise a vibration sensor for detecting the vibrations caused by the activity of the injection device 106 , such as the rotation of the knob 120 and/or the pressing of the button 116 .
  • the number of clicks detected by the vibration sensor may indicate the amount of drug injected by the user.
  • the vibration sensor may detect the direction of the rotation of the knob 120 , which as described, may correspond to addition or removal of the drug for injection thereof.
  • the vibration sensor may comprise a microphone or a plurality of microphones 144 .
  • the signal may be a movement signal generated by an activity performed by the injection device 106 .
  • the sensor 140 may comprise a movement sensor for detecting the displacement caused by the activity of the injection device 106 , such as the rotation of the knob 120 and/or the pressing of the button 116 .
  • the number of clicks detected by the displacement sensor may indicate the amount of drug injected by the user.
  • the displacement sensor may detect the direction of the rotation of the knob 120 , which as described, may correspond to addition or removal of the drug for injection thereof.
  • the movement sensor may comprise a magnetic sensor or an electromagnetic sensor configured to detect an angular displacement caused by the rotation of the knob 120 .
  • An electromagnetic encoder may be provided therewith
  • the movement sensor may comprise an electromechanical sensor, an optical sensor, a microphone, a vibration sensor, an accelerometer, a rotational sensor, a combination thereof or any other suitable sensor for detecting movement of the injection device 106 or any other activity related thereto.
  • a laser diode and an optical detector may be used for detecting movement.
  • the signal may be an optical signal generated by an activity performed by the injection device 106 .
  • the sensor 140 may comprise an optical sensor, such as a CCD which may image the display window 126 .
  • the display window 110 may display dose information set for injecting into a user, and the CCD may be configured to capture the dose information from the window 126 .
  • An optical element configured with the sleeve 134 to be arranged adjacent the display window 110 may be provided. Such an optical element may comprise one or more lenses.
  • the tracking device 102 may comprise a coupling material provided to efficiently couple and transform the signal, such as the auditory signal, from the injection device 106 to the tracking device 102 .
  • the coupling material may comprise a sound conducting material.
  • the tracking device 102 may include an isolating material to isolate noises and other sound sources external to the injection device 106 .
  • the tracking device 102 may comprise an identifier 146 comprising any suitable component for identifying the tracking device 102 and/or the injection device 106 .
  • the identifier may comprise an RFID sticker and/or a Subscriber Identification Module (SIM) card.
  • the senor 140 upon detecting the selected amount of drug, may inform the user, via a speaker 148 or by any other announcement means. This enables visually impaired insulin dependent diabetics to correctly set the injection device 106 to the correct amount.
  • the tracking device 102 may comprise electrical components and a transmission element 150 for transmitting the detected signal or data related thereto to an external unit 154 .
  • the transmission element 150 may comprise any element configured to pass the signal from the tracking device 102 thereon.
  • the transmission element 150 may comprise for example, a transmitter, a transponder, an antenna, a transducer, and/or an RLC circuit.
  • the electrical components may comprise any suitable components for detecting, processing, storing and/or transmitting a signal, such as electrical circuitry, an analog-to-digital (A/D) converter, and an electrical circuit for analog or digital short range communication, for example
  • the external unit 154 may be any apparatus configured to receive the detected signal or data related thereto for processing thereof and/or for further transmitting the detected signal or data related thereto to a central database 158 .
  • the external unit 154 may comprise any one of a computer, a cellular phone, smartphone, or a tablet.
  • the external unit 154 may comprise a glucose meter.
  • the external unit 154 may comprise a treatment device 160 ( FIG. 8 ) worn on the skin of a user to treat an injection site to improve the pharmacodynamics of the drug during a period of delivery of the drug to the user.
  • the injection site may be an intradermal layer.
  • the treatment device 160 may comprise a treatment device disclosed in applicant's PCT patent application PCT/IB2009/007600 or PCT/IB2012/052335, all incorporated herein by reference in their entireties and may be referred to in this disclosure as the “INSUPAD®”.
  • the central database 158 may comprise any suitable device or function for storage of the data and/or analysis thereof.
  • the central database may comprise a processor and/or memory.
  • the central database 158 may comprise a computer, PC, laptop, tablet, smartphone, media player or personal data assistant (“PDA”).
  • PDA personal data assistant
  • the drug dispensing-tracking system 100 may comprise a processor for processing the detected signal and/or data received from the tracking device 102 .
  • a memory may also be provided for storing the detected signal and/or data.
  • the external unit 154 may comprise a processor 170 .
  • the sensor 140 may generate a second signal in response to the detected signal.
  • the second signal may be transmitted via transmission element 150 to the external unit 154 .
  • the external unit processor 170 may process and analyze the second signal and convert it to data.
  • the data may be transmitted to the central database 158 .
  • the data may be transmitted to the central database 158 at the time the detected signal is generated, namely transmission in real-time.
  • the data may be relayed via wireless or wired connection by the external unit 154 to the central database 158 .
  • the external unit 154 may comprise a memory 172 .
  • the data may be stored in the memory 172 and may be transmitted thereafter to the central database 158 .
  • the tracking device may comprise a processor 180 .
  • the detected signal and/or the second signal may be processed and analyzed and converted to data by the processor 180 .
  • the data may be transmitted to the external unit 154 or may be first stored in a memory 182 of the tracking device 102 and thereafter may be transmitted from the tracking device memory 182 the external unit 154 .
  • the external unit 154 may transmit the data to the central database 158 .
  • the data may be further processed by the injection device processor 170 and thereafter may be transmitted to the central database 158 .
  • the data may be further processed by the injection device processor 170 , stored in the injection device memory 172 and thereafter may be transmitted to the central database 158 .
  • the data may be transmitted from the tracking device processor 180 or the tracking device memory 182 directly to the central database 158 or concurrently with transmission to the external unit 154 .
  • the senor 140 may be configured to detect signals in any suitable detection pattern determining the detection duration and frequency of detection in the duration.
  • Some exemplary detection patterns may be selected as follows:
  • the senor 140 may be frequently or periodically sampled by the tracking device 102 processor 180 and/or external unit processor 170 .
  • the senor 140 may be configured to detect a signal automatically, such as upon an injection event or activity and/or at predetermined time periods.
  • the injection event may include the injection of the drug.
  • An example of a tracking device 102 detecting a signal upon use of the injection device 106 is described in reference to FIGS. 6A-7 .
  • the sensor 140 may be configured to detect a signal automatically, such as upon a pre-injection event proceeding or anticipating the injection event.
  • the tracking device 102 may comprise an element (e.g., a sensor) configured for the automatic detection of an injection event (e.g., an injection event sensor).
  • This element may be monitored by processor 180 via software associated therewith, to sense when an injection activity is performed.
  • the injection event sensor may be prompted by communication between the electrical components of the tracking device 102 and electrical components of the external unit 154 .
  • the external unit 154 comprises a blood glucose meter
  • the injection event sensor may detect a blood glucose measurement.
  • the injection event sensor may detect activation of the treatment device 160 .
  • the activity of the external unit 154 e.g. a blood glucose measurement or activation of the treatment device 160
  • this activity may be used to signal that an injection is expected to be performed, thereby activating sensor 140 .
  • the detection occurs around the injection event, thus reducing unnecessary detection, and hence preserving the operation power of the tracking device 102 .
  • the sensor 140 may be frequently or periodically sampled by the tracking device processor 180 and/or external unit processor 170 .
  • the tracking device 102 may be preset to detect at predetermined time intervals, generally when basal drug doses are injected, such as for example in the morning and/or at night.
  • the tracking device 102 may comprise a switch 188 or a component configured to prompt the sensor 140 to detect a signal.
  • the switch 188 may be switched on by a user or in response to any other event, such as by a signal provided by the external unit 154 .
  • the external unit 154 comprises a treatment device 160
  • the operation of the treatment device 160 may be used to switch on the switch 188 .
  • the switch may be positioned in, on or adjacent to the rotating element (e.g. the cap 130 ) of the injection device.
  • the switch may be toggled between two or more states by the user, including, for example, a state for switching on the tracking device 102 and turning off the tracking device 102 .
  • the switch 188 may be toggled between an “off” state and an “on” state in response to any suitable trigger, such as the operation of the injection device 106 or the rotation direction of the rotation knob 120 .
  • the states may comprise at least one of: a state for turning on the tracking device 102 , a state indicating the direction of the injection device movement as it is set by the user to the amount of the injected drug, a state indicating re-adjustment of an amount of drug before injection, and a state indicating the drug is to be injected.
  • the external unit 154 may comprise a switch or a component configured to detect the second signal transmitted from the tracking device 102 .
  • the external unit 154 may include a proximity detector for detecting the presence of the tracking device 102 when in proximity thereto, thereby triggering the external unit 154 to detect the second signal transmitted from the tracking device 102 .
  • the data may comprise any data related to the activity of the injection device 106 , such as the amount of injected drug, the injection time, the injection duration.
  • the data may comprise information related to the type of drug as well as identification of the injection device 106 and/or the tracking device 102 .
  • different types and/or quantities if insulin are administrated, such as a basal insulin dose and a bolus insulin dose.
  • the different doses may be injected by different injection devices 106 . Therefore, data indicating the type of injected dose assists the user, caretaker or physician in monitoring the course of correct treatment.
  • the data may comprise time information corresponding to the date and time of a respective injection.
  • the tracking device 102 and or the external unit 154 may be programmed to anticipate injection of the drug at predetermined periods and with predetermined amount or dosage. Accordingly, the data may also indicate omission of an anticipated injection or incorrect dosage.
  • the data may be used to monitor the expiration of the drug. This may be determined by measuring the time discrepancy between the first use of the injection device 106 and a current time or by comparing the date of the drug injection with an expiration date provided by the drug manufacturer.
  • the tracking device 102 may include a temperature sensor and the data may detect the temperature of the drug and/or the ambient environment. The temperature measurement may be used to indicate overheating and hence inefficacy of the drug.
  • the temperature sensor may detect the temperature of the treatment device 160 thereby ensuring the treatment device operates properly and/or possibly adapt the injection accordingly.
  • the detected signal, second signal and/or data may be transmitted from the tracking device 102 to the external unit 154 , and to the central database 158 ; and/or from the tracking device 102 to the central database 158 in any suitable manner, such as wirelessly, via an analog short range communication mode, or a digital communication mode including WIFI or Bluetooth, or via a wired connection. Additional examples for transmission may be via a network.
  • the network may comprise a local area network (LAN), a wide area network (WAN), or a global network, for example.
  • the network may be part of, or comprise any suitable networking system, such as the Internet, for example, or an Intranet.
  • the term “Internet” may refer to the worldwide collection of networks, gateways, routers, and computers that use Transmission Control Protocol/Internet Protocol (“TCP/IP”) and other packet based protocols to communicate therebetween.
  • TCP/IP Transmission Control Protocol/Internet Protocol
  • the tracking device 102 may comprise an antenna 190 provided for wirelessly transmitting the signal.
  • the data may be used by a physician, caretaker or the patient to track treatment goals.
  • the data may be used with data provided by the glucose meter. Additionally, the data may be used to alert the patient upon passage of the drug expiration date. Moreover the data may be used to alert the patient upon reduction of the efficacy of the drug due to excess heat or any other relevant parameter.
  • the tracking device 102 may operate using any suitable power source 192 , such as, a battery 194 .
  • the tracking device 102 may comprise a battery enclosure 196 for removing a discharged battery 194 and replacing it with a new battery.
  • the battery 194 may be recharged by inserting the tracking device 102 (and, in some embodiments, the injection device 106 ) on a recharging cradle 198 , as shown in FIG. 5 .
  • the tracking device 102 may be connected to an electricity source via a cable.
  • FIGS. 6A-7 are illustrations of an exemplary drug dispensing-tracking system 100 .
  • a tracking device 202 may be formed with a first section 204 inserted on the shaft 108 and a second section 208 inserted on the cap 130 .
  • a mechanical connection such as at least one pin 212 ( FIG. 6B-7 ) may connect the first section 204 to the second section 208 .
  • the pins 212 may be configured to separate into two first and second portions 214 and 218 , each placed on the corresponding first section 204 and the second section 208 .
  • the sleeve 134 comprises mechanical features including the perforation 138 , and can be opened along its longitudinal axis 139 .
  • Mounting the sleeve 134 to the injection device 106 may be made when the cap 130 of the injection device 106 is mounted properly on the injection device 106 , then by opening the sleeve 134 along its longitudinal axis 139 , fitting its mechanical features to the injection device mechanical features, while the perforation 138 of the sleeve 134 is next to the area of the injection device 106 between the cap 130 and the body (e.g. the shaft 108 ) of the injection device 106 .
  • Closing the sleeve 134 in the orientation of arrow 222 may fix the perforation 138 where the cap 130 and body of the injection device connect, such that disconnecting the cap 130 from the injection device 106 breaks the perforation of the sleeve 134 , leaving first section 204 firmly affixed to the body of the injection device and second section 208 firmly affixed to the cap 130 of the injection device, as shown in FIG. 6C .
  • the first pin portion 214 disconnects from the second portion 218 .
  • the tracking device 102 is formed such that the disconnection of the pin portions 214 from 218 triggers the sensor 140 to commence its detecting operation.
  • the sensor operation may be terminated.
  • the pin 212 may comprise an activation pin configured to turn on the switch 188 upon disconnection of the first portion 214 from the second portion 218 via appropriate electrical circuitry and components.
  • the first and second portions 214 and 218 may be connected and the sensor has yet to commence its operation.
  • the first and second portions 214 and 218 are disconnected, as seen in FIGS. 6C and 7 , thereby triggering the detection operation, which may operate as described in reference to FIGS. 1-5 .
  • the operating of the tracking device 102 is switched on or off in a simple manner due to the simple, mechanical operation of the pins 212 .
  • the tracking device 102 may be configured to be used with a single (disposable or multiple use) injection device 106 . In some embodiments the tracking device 102 or 202 may be configured for multiple use and may be placed on a plurality of injection devices 106 .
  • FIG. 8 is a schematic illustration of an exemplary drug dispensing-tracking system 100 according to some embodiments. As seen in FIG. 8 , a user may use different injection devices during the treatment course, such as a first injection device 230 in the morning and a second injection device 234 at night.
  • Each injection device 106 may be designed with different mechanical, electrical and/or pharmaceutical features, as common in the commercial injection device market. Accordingly, the tracking devices 102 may be configured to fit the features of the different injection devices. For example, the injection device 106 may be formed with unique mechanical features and the tracking device 102 may be formed with corresponding mechanical features.
  • each commercial injection device 106 may be configured to inject a selected drug and a selected dose
  • identifying the corresponding sleeve may also identify the selected drug and a selected dose. This identifying information may be transmitted to the external unit 154 and/or central database 158 .
  • the sensor 140 of a first tracking device 240 may be calibrated to detect an injection of a first drug or dosage by the first injection device 230 .
  • a sensor 140 of a second tracking device 244 may be calibrated to detect an injection of a second drug or dosage by the second injection device 234 .
  • Each injection device 230 or 234 may include a unique identifier and the unique identification may be transmitted to the external unit 154 , here shown as the treatment device 160 .
  • the carrier frequency of the signal from the sensor 140 may be utilized as the unique identifier of a specific type of injection device 106 .
  • the external unit 154 may include electronics with several electronic filters, at least some used to detect signals broadcasted from a different injection device 106 , allowing the external unit 154 to analyze signals from different injection device 106 and record the amount of drug injected from each one of them along with time and date information or any other relevant data.
  • the data from the different tracking devices 240 and 244 may be transmitted via the external unit 154 (or directly) to the central database 158 .
  • systems, methods and devices may collect, store and log data from a plurality of injection events and/or injection devices, which, without the tracking device according to some embodiments, would be lost.
  • FIG. 9 is a graph illustrating a method for tracking dispensing of a drug from the injection device 106 according to some embodiments.
  • the algorithm may provide a sum which represents the amount of drug to be injected.
  • FIG. 9 shows an injection event where the total rotations in the first direction is 8 (shown as the downwardly oriented signals 250 ) and the total rotations in the opposite direction is 2 (shown as the upwardly oriented signals 260 ).
  • rotation in the first direction indicates adding a predetermined drug amount X
  • rotation in the second, opposite direction indicates subtracting the predetermined drug amount X.
  • the sleeve 134 may comprise microphone 144 , power source 192 , switch 188 , and transmission element 150 , and may be attached to each injection device 106 by the user. After the user completes setting the injection device 106 to the desired amount of drug by setting the rotation knob 120 of the injection device 106 , the user may use the switch 188 on the sleeve 134 to turn “on” the sleeve 134 . When the injection is performed, the electronics of the sleeve 134 may wirelessly transmit by transmission methods known in the art, the sound and vibration created, to the external unit 154 .
  • the processor 170 of the external unit 154 (which can be a treatment device, such as treatment device 160 ) may analyze the information to find the amount of drug injected and either store the information in the external unit memory 172 for later download, or transmit the information in real-time to the central database 158 .
  • the sleeve 134 may include microphone 144 , power source 192 , processor 180 and a transmission element 150 comprising a transmitter.
  • the microphone 144 may be frequently sampled by the processor 180 to analyze the sound and/or vibration created when the rotation knob 120 of the injection device 106 is turned in order to detect an injection event. When the user “sets” the injection device 106 the microphone 144 may pick up the sound and/or vibration created during the setting event.
  • the processor 180 analyzes that the setting event is completed, it may be configured to activate the transmitter. The sound and/or vibration created (or corresponding data associated therewith) when the drug is injected may then be transmitted wirelessly to the external unit 154 .
  • the processor 180 on the sleeve 134 may distinguish between these two events and turn on the transmitter only before the drug is injected (thereby preserving battery power).
  • the processor 170 of the external unit 154 may analyze the received signal/data to determine the amount of drug that was just injected.
  • injection devices have a protective cap 130 that is removed before injection is made. Therefore, in accordance with some embodiments of the present disclosure, the sleeve electronics may be turned “on” when the cap 130 is removed. The microphone signal/data may be then transmitted wirelessly to the external unit 154 to be analyzed in order to determine the amount of drug that was just injected.
  • the tracking device 102 may be formed with a mechanical attachment to the injection device 106 .
  • the mechanical attachment can be separated to a part which fits the cap 130 (shown in FIGS. 6A-6C as second section 208 ) and a part (shown as first section 204 ) that fits the injection device body (e.g. the shaft 108 ).
  • the part which fits the cap 130 may have at least one activation pin 212 extending out. These one or more activation pins 212 may contact the switch 188 inside the part of the sleeve 134 that mechanically fits the injection device body (e.g. the shaft 108 ).
  • the part of the sleeve 134 that fits the injection device body may further include the electrical circuit, power source 192 , microphone 144 , wireless transponder and, in some embodiments, the processor 180 and memory 182 .
  • the activation pin 212 disconnects from the switch 188 and this turns on the electrical components of the circuit on the sleeve part which fits the injection device body. This may be configured to thereby activate the microphone 144 , the transmitter and/or transponder, and in some embodiments, the processor 180 , to measure the amount of drug that was injected and transmits the data to the external unit 154 .
  • the injection device 106 may be provided with wireless cellular capabilities. In such injection devices 106 , with each injection the injection information may be wirelessly transmitted and logged in a central database 158 for real-time analysis and feedback to the user.
  • the drug dispensing-tracking system 100 for capturing, transferring and logging injection event information to the central database 158 in real-time or periodically may comprise: an injection device with cellular wireless transmission capabilities, or an injector device adaptor (e.g. the tracking device 102 ) comprising: a mechanical attachment body (e.g. the sleeve 134 ) configured for mounting with (e.g., in and/or on) the injection device 106 , battery 194 and electronics to sense and transmit to the external unit 154 injection information, of injections made by the injection device.
  • the drug dispensing-tracking system 100 may further comprise external unit 154 , and/or the injection device adaptor can capture, analyze, store and transmit injection information to central database 158 .
  • the external unit 154 may comprise at least one of a blood glucose meter, a treatment device 160 , a cellular phone/device, and any other device in wireless communication with the injection device.
  • several microphones 144 may be arranged in the sleeve 134 , as seen in FIG. 4 .
  • the processor 180 on the sleeve, and/or the processor 170 of the external unit 154 may be configured to analyze the signal from the microphones 144 to determine the direction to which the rotation knob 120 is rotated.
  • At least one microphone 144 may be placed inside the external unit 154 to detect the sound created when the rotation knob 120 is rotated.
  • a controller of the external unit 154 may analyze the signal from the at least one microphone 144 to determine the amount of drug that was injected by the injection device 106 .
  • the transmission of data or sound signal between the injection device electronics to the external unit 154 may be done using any of Bluetooth short range digital communication modes or an analog communication mode.
  • external unit 154 may be set to detect a signal coming from the injection device 106 at predetermined times or following certain activity of the external unit 154 .
  • activity of the external unit 154 can be, for example in the case of an INSUPAD, activation of the INSUPAD just before injection, which in a certain configuration of the INSUPAD is done by opening the INSUPAD to reveal the injection window 126 .
  • the external unit 154 comprises a blood glucose meter
  • the activity can be performing a blood glucose measurement, which is usually done before injection.
  • predetermined time intervals they can be preset to be in the morning or night, and will be used to detect basal injections which are usually given during theses time windows.
  • the external unit 154 may comprise a button which is pressed by the user to move the unit to a mode where it is ready to detect the signal coming from the sleeve 134 .
  • the external unit 154 may comprise a proximity detector which may detect the presence of the sleeve 134 next to it and trigger a receiver of the external unit 154 to detect the signals coming from the sleeve 134 .
  • any combination of the preceding methods can be used in order to move the external unit 154 to a mode where it is ready to detect the signals coming from the sleeve 134 and find out from that data the amount of drug that was injected.
  • the sleeve 134 may include a coupling material in the interface between the sleeve 134 and the injection device 106 to efficiently couple the sound from the injection device 106 into the sleeve 134 .
  • an external interface of the sleeve 134 may include an isolating material on its outer face 230 to isolate noise and other sound sources from the external surrounding.
  • the processor which analyzes the signal to determine the amount of insulin injected may use an algorithm which detects the different impulses present in the audio signal which are associated with the different insulin units which were injected. Those sound impulses can be detected during the initial settings of the dose when rotating the cap 130 to its initial pre-injection stage. Those sound impulses can be detected during the injection step when the cap 130 is pressed and insulin is injected and a series of sound clicks is heard. Those sound impulses can be detected also from both the sound clicks during initial dose setting and during the injection event.
  • the processor which analyzes the signal to determine the amount of insulin injected may use a simple comparing algorithm where a train of sound impulses is compared to a train of a pre-recorded sound impulses to determine the amount of insulin injected.
  • the memory of the processor would contain multiple sound samples for each dose which can be injected by the specific type of injection device 106 , which the sleeve 134 is intended to be used with.
  • the sleeve 134 may contain a listening element (i.e. microphone 144 ), processor 180 to analyze the signal and a speaker 148 .
  • the sleeve 134 detects the amount of insulin units set by the user to inject and the microphone 144 may announce to the user the amount of insulin units which the injection device 106 is set to inject. This may enable visually impaired insulin dependent diabetic subjects to correctly set their insulin injector to the correct amount.
  • the sleeve 134 may contain a RFID sticker to identify the injection device.
  • Various implementations of some of embodiments disclosed, in particular at least some of the processes discussed (or portions thereof), may be realized in digital electronic circuitry, integrated circuitry, specially configured ASICs (application specific integrated circuits), computer hardware, firmware, software, and/or combinations thereof.
  • ASICs application specific integrated circuits
  • These various implementations, such as associated with the drug dispensing-tracking system 100 and the components thereof, for example, may include implementation in one or more computer programs that are executable and/or interpretable on a programmable system including at least one programmable processor, which may be special or general purpose, coupled to receive data and instructions from, and to transmit data and instructions to, a storage system, at least one input device, and at least one output device.
  • Such computer programs include machine instructions/code for a programmable processor, for example, and may be implemented in a high-level procedural and/or object-oriented programming language, and/or in assembly/machine language.
  • machine-readable medium refers to any computer program product, apparatus and/or device (e.g., non-transitory mediums including, for example, magnetic discs, optical disks, flash memory, Programmable Logic Devices (PLDs)) used to provide machine instructions and/or data to a programmable processor, including a machine-readable medium that receives machine instructions as a machine-readable signal.
  • machine-readable signal refers to any signal used to provide machine instructions and/or data to a programmable processor.
  • the subject matter described herein may be implemented on a computer having a display device (e.g., a LCD (liquid crystal display) monitor and the like) for displaying information to the user and a keyboard and/or a pointing device (e.g., a mouse or a trackball, touchscreen) by which the user may provide input to the computer.
  • a display device e.g., a LCD (liquid crystal display) monitor and the like
  • a keyboard and/or a pointing device e.g., a mouse or a trackball, touchscreen
  • this program can be stored, executed and operated by the dispensing unit, remote control, PC, laptop, smartphone, media player or personal data assistant (“PDA”).
  • PDA personal data assistant
  • Other kinds of devices may be used to provide for interaction with a user as well.
  • feedback provided to the user may be any form of sensory feedback (e.g., visual feedback, auditory feedback, or tactile feedback), and input from the user may be received in any form, including acoustic, speech, or tactile input.
  • Certain embodiments of the subject matter described herein may be implemented in a computing system and/or devices that includes a back-end component (e.g., as a data server), or that includes a middleware component (e.g., an application server), or that includes a front-end component (e.g., a client computer having a graphical user interface or a Web browser through which a user may interact with an implementation of the subject matter described herein), or any combination of such back-end, middleware, or front-end components.
  • a back-end component e.g., as a data server
  • middleware component e.g., an application server
  • a front-end component e.g., a client computer having a graphical user interface or a Web browser through which a user may interact with
  • the components of the system may be interconnected by any form or medium of digital data communication (e.g., a communication network).
  • Examples of communication networks include a local area network (“LAN”), a wide area network (“WAN”), and the Internet.
  • the computing system according to some such embodiments described above may include clients and servers.
  • a client and server are generally remote from each other and typically interact through a communication network.
  • the relationship of client and server arises by virtue of computer programs running on the respective computers and having a client-server relationship to each other.
  • features from one and/or another disclosed embodiment may be interchangeable with features from other disclosed embodiments, which, in turn, correspond to yet other embodiments.
  • one or more features/elements of disclosed embodiments may be removed and still result in patentable subject matter (and thus, resulting in yet more embodiments of the subject disclosure).

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Primary Health Care (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Electromagnetism (AREA)
  • General Physics & Mathematics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
US14/438,177 2012-10-23 2013-10-22 Drug dispensing-tracking device, system and method Abandoned US20150290396A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/438,177 US20150290396A1 (en) 2012-10-23 2013-10-22 Drug dispensing-tracking device, system and method

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261717292P 2012-10-23 2012-10-23
US201261727709P 2012-11-18 2012-11-18
US201361762914P 2013-02-10 2013-02-10
US14/438,177 US20150290396A1 (en) 2012-10-23 2013-10-22 Drug dispensing-tracking device, system and method
PCT/IL2013/050857 WO2014064691A2 (fr) 2012-10-23 2013-10-22 Dispositif, système et procédé de suivi d'administration de médicament

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2013/050857 A-371-Of-International WO2014064691A2 (fr) 2012-10-23 2013-10-22 Dispositif, système et procédé de suivi d'administration de médicament

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/289,496 Continuation US10842943B2 (en) 2012-10-23 2019-02-28 Drug dispensing-tracking device, system and method

Publications (1)

Publication Number Publication Date
US20150290396A1 true US20150290396A1 (en) 2015-10-15

Family

ID=50545419

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/438,177 Abandoned US20150290396A1 (en) 2012-10-23 2013-10-22 Drug dispensing-tracking device, system and method
US16/289,496 Active US10842943B2 (en) 2012-10-23 2019-02-28 Drug dispensing-tracking device, system and method

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/289,496 Active US10842943B2 (en) 2012-10-23 2019-02-28 Drug dispensing-tracking device, system and method

Country Status (3)

Country Link
US (2) US20150290396A1 (fr)
EP (1) EP2911717B1 (fr)
WO (1) WO2014064691A2 (fr)

Cited By (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150246179A1 (en) * 2014-03-02 2015-09-03 Nissim Zur Device and method for drug dosing with administration monitoring, in particular for insulin pen integrated with smart phone apps.
US20160129182A1 (en) * 2013-07-12 2016-05-12 Oscillari Llc Vibration sensor based drug delivery monitor
EP3162398A1 (fr) * 2015-10-30 2017-05-03 Carebay Europe Ltd. Dispositif d'administration de médicament avec capteur de vibration
US20170182258A1 (en) * 2015-12-29 2017-06-29 InsuLog Ltd. Adjunct device and system for an injector for monitoring injected amounts
US9767708B2 (en) 2012-04-04 2017-09-19 Genia Medical Inc. Medicament training device and system
US20170323553A1 (en) * 2013-08-28 2017-11-09 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
WO2018009509A3 (fr) * 2016-07-06 2018-02-22 Quio Technologies Llc Ensemble d'administration de médicament pour médicaments sous forme de cartouches
US20180289901A1 (en) * 2017-04-06 2018-10-11 Nordic Healthcare Advisory Aps Position determination device and system for determining and registering an injection location
WO2019032784A1 (fr) * 2017-08-10 2019-02-14 Medimmune, Llc Accessoire de dispositif pour la surveillance numérique d'un injecteur automatique pour améliorer l'observance, le patient à distance et l'adhérence
WO2019040313A1 (fr) * 2017-08-21 2019-02-28 Eli Lilly And Company Dispositif d'administration de médicament doté d'un système de détection
CN109414548A (zh) * 2016-07-15 2019-03-01 伊莱利利公司 用于药物输送装置的剂量检测模块
EP3476417A1 (fr) * 2017-10-31 2019-05-01 Tecpharma Licensing AG Surveillance de dispositifs d'injection jetables
US10283014B2 (en) 2012-04-04 2019-05-07 Jbcb Holdings, Llc Smart packaging and display system
US20190192782A1 (en) * 2016-05-30 2019-06-27 Novo Nordisk A/S Mounting feature for accessory device
WO2019121612A1 (fr) * 2017-12-21 2019-06-27 Sanofi Détermination d'un état d'injection
WO2019170429A1 (fr) * 2018-03-08 2019-09-12 Robert Bosch Gmbh Système d'administration de médicament
CN111712283A (zh) * 2017-12-21 2020-09-25 赛诺菲 注射装置使用情况的声学检测
US20210085880A1 (en) * 2018-05-22 2021-03-25 Ypsomed Ag Click event identification in delivery devices
US20210098108A1 (en) * 2016-01-29 2021-04-01 Companion Medical, Inc. Automatic medication delivery tracking
US10987472B2 (en) 2017-02-28 2021-04-27 Eli Lilly And Company Dose detection for a medication delivery device
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11027073B2 (en) 2017-12-12 2021-06-08 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
US11071831B2 (en) 2018-02-22 2021-07-27 Eli Lilly And Company Dose detection system module for medication delivery device
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US11123488B2 (en) 2018-10-03 2021-09-21 Eli Lilly And Company Status sensing systems within an injection device assembly
WO2021219460A1 (fr) * 2020-04-29 2021-11-04 Shl Medical Ag Dispositif concentrateur pour un dispositif médical portatif
US11191905B2 (en) * 2016-10-14 2021-12-07 Shl Medical Ag Monitoring device
US11197964B2 (en) 2017-12-12 2021-12-14 Bigfoot Biomedical, Inc. Pen cap for medication injection pen having temperature sensor
US20220008658A1 (en) * 2016-07-15 2022-01-13 Bigfoot Biomedical, Inc. Dose measurement systems and methods
EA039524B1 (ru) * 2018-05-25 2022-02-07 Эли Лилли Энд Компани Устройство для доставки лекарственного препарата с измерительной системой
US11285268B2 (en) * 2016-01-06 2022-03-29 Sanofi-Aventis Deutschland Gmbh Medicament delivery device
US11291771B2 (en) * 2016-11-09 2022-04-05 Ypsomed Ag Electronic add-on module for injection appliances
US11351308B2 (en) 2015-12-09 2022-06-07 Amgen Inc. Auto-injector with signaling cap
US11357926B2 (en) 2017-05-09 2022-06-14 Novo Nordisk A/S Drug delivery device with sound transducer
US11406768B2 (en) 2016-10-03 2022-08-09 Ypsomed Ag Electronic module for monitoring injection devices
US11464459B2 (en) 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US11464912B2 (en) 2016-05-30 2022-10-11 Novo Nordisk A/S Drug delivery device with zero position adjustment feature
US11529470B2 (en) 2017-08-21 2022-12-20 Eli Lilly And Company Dose detection module for a medication delivery device
US11602596B2 (en) 2017-10-31 2023-03-14 Ypsomed Ag Safety-critical drug delivery parameter determination
USD985118S1 (en) 2021-03-10 2023-05-02 Amgen Inc. Handheld drug delivery device
USD985116S1 (en) 2021-03-10 2023-05-02 Amgen Inc. Handheld drug delivery device
USD985117S1 (en) 2021-03-10 2023-05-02 Amgen Inc. Handheld drug delivery device
USD985119S1 (en) 2021-03-30 2023-05-02 Amgen Inc. Handheld drug delivery device
US11666701B2 (en) * 2016-04-28 2023-06-06 Embecta Corp. Smart medication delivery devices for providing users with delivery infomatics and methods of using same
USD990668S1 (en) 2020-11-05 2023-06-27 Amgen Inc. Handheld drug delivery device
USD992109S1 (en) 2020-11-05 2023-07-11 Amgen Inc. Handheld drug delivery device
USD1001272S1 (en) 2016-04-28 2023-10-10 Amgen Inc. Autoinjector with removable cap
USD1004078S1 (en) 2019-09-30 2023-11-07 Amgen Inc. Handheld drug delivery device
US11833333B2 (en) 2017-07-12 2023-12-05 Insuline Medical Ltd Drug tracking device
USD1010107S1 (en) 2020-11-05 2024-01-02 Amgen Inc. Handheld drug delivery device
USD1030040S1 (en) 2020-01-14 2024-06-04 Amgen Inc. Handheld drug delivery device
USD1030041S1 (en) 2020-01-14 2024-06-04 Amgen Inc. Handheld drug delivery device
USD1048382S1 (en) 2024-03-08 2024-10-22 Amgen Inc. Autoinjector with removable cap

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2689359T3 (da) 2011-03-24 2021-02-08 Sanofi Aventis Deutschland Apparat og fremgangsmåde til påvisning af en aktiveringshandling, der kan udføres med en medicinsk anordning
MX2013013157A (es) 2011-05-10 2015-01-22 Insuline Medical Ltd Dispositivo, sistema y metodo para facilitar el suministro de un farmaco con una jeringa y manejo del mismo.
ITCO20130017A1 (it) * 2013-05-16 2014-11-17 Egriot S R L Dispositivo di controllo e sistemi di controllo e verifica dell'assunzione di farmaci
SG11201609966SA (en) 2014-06-03 2016-12-29 Amgen Inc Drug delivery system and method of use
DK3161693T3 (da) * 2014-06-27 2021-07-12 Sanofi Aventis Deutschland System og fremgangsmåde til overvågning
EP3169301B1 (fr) 2014-07-15 2019-06-19 Ron Nagar Dispositifs et systèmes de régulation de conditions et d'administration de substances
US10569028B2 (en) 2014-11-05 2020-02-25 Insuline Medical Ltd. Drug tracking device
US10258745B2 (en) * 2015-01-23 2019-04-16 Becton, Dickinson And Company Method and device for capturing a dose dialing event
EP3058970A1 (fr) 2015-02-19 2016-08-24 Sanofi-Aventis Deutschland GmbH Dispositif de collecte de données destiné à être fixé à un dispositif d'injection
CA2978266A1 (fr) * 2015-03-02 2016-09-09 Biogen Ma Inc. Indicateur de dose d'administration de medicament
HUE050055T2 (hu) 2015-06-09 2020-11-30 Sanofi Aventis Deutschland Adatgyûjtõ berendezés befecskendezõeszközhöz erõsítésre
EP3103492A1 (fr) * 2015-06-09 2016-12-14 Sanofi-Aventis Deutschland GmbH Dispositif de collecte de donnees destine a etre fixe a un dispositif d'injection
WO2016204879A1 (fr) * 2015-06-19 2016-12-22 Valeritas, Inc. Système de surveillance de distribution de fluide
US20170035960A1 (en) * 2015-08-05 2017-02-09 Lifescan Scotland Limited Mechanically actuated infusion device having dose counter
EP3380057B1 (fr) 2015-11-23 2024-08-14 Ron Nagar Dispositifs, systèmes et procédé de régulation de conditions environnementales de substances
JP6910355B2 (ja) * 2015-12-10 2021-07-28 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 取り外し可能に取り付け可能なセンサデバイスを備える薬物送達デバイス
DE102016203905A1 (de) * 2016-03-10 2017-09-14 Robert Bosch Gmbh Erfassungseinrichtung zum Erfassen eines eine Dosis eines Dosiergeräts repräsentierenden Werts und Verfahren zum Betreiben desselben
CN109219459B (zh) * 2016-05-24 2021-11-16 赛诺菲-安万特德国有限公司 附接于药物输送装置的补充装置、药物输送装置的数字套筒和药物输送装置
EP3484555B1 (fr) * 2016-07-18 2023-11-29 Roche Diabetes Care GmbH Dispositif de génération de données de protocole pour un stylo d'injection
EP3534992B1 (fr) 2016-11-01 2020-12-30 Sanofi-Aventis Deutschland GmbH Dispositif auxiliaire pour un dispositif d'injection
WO2018111969A1 (fr) * 2016-12-14 2018-06-21 Medimmune, Llc Capteur multi-composants intégré dans une tige de piston pour capturer et transmettre des informations d'injection
CN110290821B (zh) * 2017-02-28 2022-03-29 艾斯曲尔医疗公司 监测装置
EP3381493B1 (fr) * 2017-03-30 2023-06-07 Ypsomed AG Unité électronique pour dispositifs d'injection
US11986639B2 (en) 2017-09-22 2024-05-21 Novo Nordisk A/S Accessory device for drug delivery device
WO2019170401A1 (fr) * 2018-03-08 2019-09-12 Shl Medical Ag Étui de transport pour un dispositif d'appoint d'un dispositif d'administration de médicament
US20210275753A1 (en) * 2018-08-16 2021-09-09 Boehringer Ingelheim International Gmbh System for monitoring the dispensing of an administrable substance, protecting element and dispensing device
WO2020261106A1 (fr) * 2019-06-25 2020-12-30 Quio Technologies Llc Système doté d'un dispositif de surveillance
WO2021001254A1 (fr) * 2019-07-01 2021-01-07 Sanofi Électronique d'éveil dans un dispositif d'injection
WO2021095003A1 (fr) * 2019-11-13 2021-05-20 Janssen Biotech, Inc. Modules de détection de dispositif d'administration de médicament
JP2023511451A (ja) * 2020-02-07 2023-03-17 エスエイチエル・メディカル・アーゲー 薬剤送達デバイスに対して装着された補助デバイスの作動システム
JP2023529676A (ja) 2020-06-09 2023-07-11 サノフイ 薬物送達デバイスおよび用量を判定するための方法
US20240198010A1 (en) 2021-04-23 2024-06-20 Sanofi Electronic System for a Drug Delivery Device
US20240221891A1 (en) * 2021-06-18 2024-07-04 Sanofi A method and system for associating dose related data captured with and stored in an add-on device to a drug delivery device
US20240038379A1 (en) * 2021-07-30 2024-02-01 Eli Lilly And Company Techniques for processing wirelessly broadcast packets from a medical device with dose-related data
JP2024535903A (ja) * 2021-09-24 2024-10-02 サノフイ 医療デバイス用の電子システム、そのような電子システムを備えた医療デバイス、電子システムと通信するための外部デバイス、医療デバイスと外部デバイスとの間でデータを交換するための方法、並びに対応する機械可読コード及びそのようなコードを含むデータ記憶媒体
KR102677093B1 (ko) * 2022-01-25 2024-06-21 주식회사 푸른소나무 약물 주입 시스템
WO2024042222A1 (fr) * 2022-08-26 2024-02-29 Cequr Sa Dispositif complémentaire pour suivi de dose de médicament

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359719A (en) * 1980-10-06 1982-11-16 Honeywell Inc. Hall effect alarm pull station
US5536249A (en) * 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US20090069742A1 (en) * 2006-03-20 2009-03-12 Andre Larsen Electronic Module for Mechanical Medication Delivery Devices
US20090256703A1 (en) * 2007-03-15 2009-10-15 Steve Bolton System and Method for Detecting Security Features on Paper Ballots
US20110313349A1 (en) * 2009-02-27 2011-12-22 Peter Krulevitch Medical module for drug delivery pen
US20120233834A1 (en) * 2011-03-18 2012-09-20 Abbott Biotechnology Ltd. Systems, devices and methods for assembling automatic injection devices and sub-assemblies thereof
US20130197445A1 (en) * 2010-03-22 2013-08-01 Sanofi-Aventis Deutschland Gmbh Device and Method for Determining Information Related to a Medical Device
US20130245545A1 (en) * 2011-09-20 2013-09-19 Medingo Ltd. Drug Injection Devices, Systems and Methods
US20140207080A1 (en) * 2011-09-08 2014-07-24 Sanofi-Aventis Deutschland Gmbh Method and monitoring device for monitoring operation of a drug delivery device
US20140207099A1 (en) * 2011-05-10 2014-07-24 Insuline Medical Ltd Device, system and method for facilitating syringe based drug delivery and management thereof
US20150032059A1 (en) * 2012-02-13 2015-01-29 Sanofi-Aventis Deutsdchland Gmbh Supplemental device for attachment to an injection device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514230B1 (en) * 1999-10-12 2003-02-04 Novo Nordisk A/S Air shot mechanism for electronic injection devices
JP4286019B2 (ja) * 2003-02-04 2009-06-24 株式会社根本杏林堂 薬液注入システム
CA2511746C (fr) * 2003-11-06 2013-03-26 Lifescan, Inc. Stylo d'administration de medicament a organe de notification d'evenement
WO2006045524A1 (fr) * 2004-10-21 2006-05-04 Novo Nordisk A/S Dispositif d'injection avec moyen destine a signaler le temps ecoule depuis la derniere ejection
JP2009532768A (ja) * 2006-03-23 2009-09-10 ベクトン・ディキンソン・アンド・カンパニー 改良された糖尿病データ管理のためのシステムおよび方法、および使用法
US9205193B2 (en) * 2007-06-12 2015-12-08 Peter V. Boesen Self-contained medication injection system and method
US9089650B2 (en) * 2008-10-01 2015-07-28 Novo Nordisk A/S Medical assembly with monitoring device
ES2713177T3 (es) * 2008-10-28 2019-05-20 Hoffmann La Roche Un procedimiento para supervisar la operación de un dispositivo de administración de medicamentos, un módulo electrónico y un sistema de administración de medicamentos
KR101939267B1 (ko) * 2010-07-21 2019-01-16 삼성전자주식회사 주사기의 주사량 측정 장치 및 방법
US20120036018A1 (en) * 2010-08-09 2012-02-09 Digna Feliciano Dynamic, interactive activity tracking via a social media system integrated with a product marketing and/or establishment advertising system
JP2014520583A (ja) * 2011-07-07 2014-08-25 ノボ・ノルデイスク・エー／エス アドオン式の投薬取得／表示モジュールを備える薬剤送出注射ペン
JP6203198B2 (ja) * 2012-02-13 2017-09-27 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 注射デバイスへの取付けのための補助デバイス

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359719A (en) * 1980-10-06 1982-11-16 Honeywell Inc. Hall effect alarm pull station
US5536249A (en) * 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US20090069742A1 (en) * 2006-03-20 2009-03-12 Andre Larsen Electronic Module for Mechanical Medication Delivery Devices
US20090256703A1 (en) * 2007-03-15 2009-10-15 Steve Bolton System and Method for Detecting Security Features on Paper Ballots
US20110313349A1 (en) * 2009-02-27 2011-12-22 Peter Krulevitch Medical module for drug delivery pen
US20130197445A1 (en) * 2010-03-22 2013-08-01 Sanofi-Aventis Deutschland Gmbh Device and Method for Determining Information Related to a Medical Device
US20120233834A1 (en) * 2011-03-18 2012-09-20 Abbott Biotechnology Ltd. Systems, devices and methods for assembling automatic injection devices and sub-assemblies thereof
US20140207099A1 (en) * 2011-05-10 2014-07-24 Insuline Medical Ltd Device, system and method for facilitating syringe based drug delivery and management thereof
US20140207080A1 (en) * 2011-09-08 2014-07-24 Sanofi-Aventis Deutschland Gmbh Method and monitoring device for monitoring operation of a drug delivery device
US20130245545A1 (en) * 2011-09-20 2013-09-19 Medingo Ltd. Drug Injection Devices, Systems and Methods
US20150032059A1 (en) * 2012-02-13 2015-01-29 Sanofi-Aventis Deutsdchland Gmbh Supplemental device for attachment to an injection device

Cited By (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10283014B2 (en) 2012-04-04 2019-05-07 Jbcb Holdings, Llc Smart packaging and display system
US9767708B2 (en) 2012-04-04 2017-09-19 Genia Medical Inc. Medicament training device and system
US20160129182A1 (en) * 2013-07-12 2016-05-12 Oscillari Llc Vibration sensor based drug delivery monitor
US10002517B2 (en) * 2013-08-28 2018-06-19 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
US10573161B2 (en) 2013-08-28 2020-02-25 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
US20170323553A1 (en) * 2013-08-28 2017-11-09 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
AU2018282247B2 (en) * 2013-08-28 2020-10-22 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
US20150246179A1 (en) * 2014-03-02 2015-09-03 Nissim Zur Device and method for drug dosing with administration monitoring, in particular for insulin pen integrated with smart phone apps.
US20180296767A1 (en) * 2015-10-30 2018-10-18 Carebay Europe Ltd Medicament delivery device with vibration sensor
KR20180059903A (ko) * 2015-10-30 2018-06-05 케어베이 유럽 리미티드 진동 센서를 구비한 약물 전달 장치
TWI627979B (zh) * 2015-10-30 2018-07-01 卡貝歐洲有限公司 具有振動感測器的藥物輸送裝置
KR102165552B1 (ko) * 2015-10-30 2020-10-15 에스에이치엘 메디컬 아게 진동 센서를 구비한 약물 전달 장치
US10881808B2 (en) * 2015-10-30 2021-01-05 Shl Medical Ag Medicament delivery device with vibration sensor
WO2017071927A1 (fr) * 2015-10-30 2017-05-04 Carebay Europe Ltd Dispositif d'administration de médicament à capteur de vibrations
EP3162398A1 (fr) * 2015-10-30 2017-05-03 Carebay Europe Ltd. Dispositif d'administration de médicament avec capteur de vibration
US11351308B2 (en) 2015-12-09 2022-06-07 Amgen Inc. Auto-injector with signaling cap
US12029884B2 (en) 2015-12-29 2024-07-09 G. E. Ehrlich (1995) Ltd. Adjunct device and system for an injector for monitoring injected amounts
US20170182258A1 (en) * 2015-12-29 2017-06-29 InsuLog Ltd. Adjunct device and system for an injector for monitoring injected amounts
US11285268B2 (en) * 2016-01-06 2022-03-29 Sanofi-Aventis Deutschland Gmbh Medicament delivery device
US11826555B2 (en) * 2016-01-29 2023-11-28 Medtronic Minimed, Inc. Automatic medication delivery tracking
US20210098108A1 (en) * 2016-01-29 2021-04-01 Companion Medical, Inc. Automatic medication delivery tracking
US11666701B2 (en) * 2016-04-28 2023-06-06 Embecta Corp. Smart medication delivery devices for providing users with delivery infomatics and methods of using same
USD1001272S1 (en) 2016-04-28 2023-10-10 Amgen Inc. Autoinjector with removable cap
USD1023290S1 (en) 2016-04-28 2024-04-16 Amgen Inc. Autoinjector with removable cap
US11464912B2 (en) 2016-05-30 2022-10-11 Novo Nordisk A/S Drug delivery device with zero position adjustment feature
US20190192782A1 (en) * 2016-05-30 2019-06-27 Novo Nordisk A/S Mounting feature for accessory device
US10967133B2 (en) * 2016-05-30 2021-04-06 Novo Nordisk A/S Mounting feature for accessory device
US11266787B2 (en) 2016-07-06 2022-03-08 Quio Technologies Llc Drug delivery assembly for cartridge-based medicaments
WO2018009509A3 (fr) * 2016-07-06 2018-02-22 Quio Technologies Llc Ensemble d'administration de médicament pour médicaments sous forme de cartouches
US11690959B2 (en) * 2016-07-15 2023-07-04 Bigfoot Biomedical, Inc. Dose measurement systems and methods
US11554221B2 (en) 2016-07-15 2023-01-17 Eli Lilly And Company Dose detection module for a medication delivery device
US20220008658A1 (en) * 2016-07-15 2022-01-13 Bigfoot Biomedical, Inc. Dose measurement systems and methods
CN109414548A (zh) * 2016-07-15 2019-03-01 伊莱利利公司 用于药物输送装置的剂量检测模块
US11406768B2 (en) 2016-10-03 2022-08-09 Ypsomed Ag Electronic module for monitoring injection devices
US11191905B2 (en) * 2016-10-14 2021-12-07 Shl Medical Ag Monitoring device
US11291771B2 (en) * 2016-11-09 2022-04-05 Ypsomed Ag Electronic add-on module for injection appliances
US11426527B2 (en) 2017-02-28 2022-08-30 Eli Lilly And Company Dose detection for a medication delivery device
US10987472B2 (en) 2017-02-28 2021-04-27 Eli Lilly And Company Dose detection for a medication delivery device
US11541186B2 (en) 2017-02-28 2023-01-03 Eli Lilly And Company Dose detection and drug identification for a medication delivery device
US11458259B2 (en) 2017-04-06 2022-10-04 Nordic Healthcare Advisory Aps Injection location and/or dosage determination device and system for a liquid drug administration device or system
US20180289901A1 (en) * 2017-04-06 2018-10-11 Nordic Healthcare Advisory Aps Position determination device and system for determining and registering an injection location
US11357926B2 (en) 2017-05-09 2022-06-14 Novo Nordisk A/S Drug delivery device with sound transducer
US11833333B2 (en) 2017-07-12 2023-12-05 Insuline Medical Ltd Drug tracking device
WO2019032784A1 (fr) * 2017-08-10 2019-02-14 Medimmune, Llc Accessoire de dispositif pour la surveillance numérique d'un injecteur automatique pour améliorer l'observance, le patient à distance et l'adhérence
US11482315B2 (en) 2017-08-10 2022-10-25 Medimmune, Llc Device accessory for digitally monitoring autoinjector usage for improved compliance, remote patient monitoring, and adherence
CN110944698A (zh) * 2017-08-21 2020-03-31 伊莱利利公司 具有感测系统的药物递送装置
WO2019040313A1 (fr) * 2017-08-21 2019-02-28 Eli Lilly And Company Dispositif d'administration de médicament doté d'un système de détection
AU2018321269B2 (en) * 2017-08-21 2021-03-25 Eli Lilly And Company Medication delivery device with sensing system
US11638785B2 (en) 2017-08-21 2023-05-02 Eli Lilly And Company Medication delivery device with sensing system
AU2021203847B2 (en) * 2017-08-21 2023-02-16 Eli Lilly And Company Medication Delivery Device With Sensing System
EP4079350A1 (fr) * 2017-08-21 2022-10-26 Eli Lilly and Company Dispositif d'administration de médicament doté d'un système de détection
US11471608B2 (en) 2017-08-21 2022-10-18 Eli Lilly And Company Medication delivery device with sensing system
US11918792B2 (en) 2017-08-21 2024-03-05 Eli Lilly And Company Dose detection module for a medication delivery device
US11529470B2 (en) 2017-08-21 2022-12-20 Eli Lilly And Company Dose detection module for a medication delivery device
US11771837B2 (en) 2017-08-21 2023-10-03 Eli Lilly And Company Medication delivery device with sensing system
EP4101485A1 (fr) * 2017-08-21 2022-12-14 Eli Lilly and Company Dispositif d'administration de médicament doté d'un système de détection
WO2019087001A1 (fr) * 2017-10-31 2019-05-09 Tecpharma Licensing Ag Surveillance de dispositifs d'injection jetables
EP3476417A1 (fr) * 2017-10-31 2019-05-01 Tecpharma Licensing AG Surveillance de dispositifs d'injection jetables
US12017048B2 (en) * 2017-10-31 2024-06-25 Ypsomed Ag Monitoring of disposable injection devices
US20200261654A1 (en) * 2017-10-31 2020-08-20 Ypsomed Ag Monitoring of disposable injection devices
US11602596B2 (en) 2017-10-31 2023-03-14 Ypsomed Ag Safety-critical drug delivery parameter determination
US11844923B2 (en) 2017-12-12 2023-12-19 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11464459B2 (en) 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US11383043B2 (en) 2017-12-12 2022-07-12 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
US11957884B2 (en) 2017-12-12 2024-04-16 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US11944465B2 (en) 2017-12-12 2024-04-02 Bigfoot Biomedical, Inc. Monitor user interface for diabetes management systems including flash glucose
US11547805B2 (en) 2017-12-12 2023-01-10 Bigfoot Biomedical, Inc. Therapy management systems, methods, and devices
US11197964B2 (en) 2017-12-12 2021-12-14 Bigfoot Biomedical, Inc. Pen cap for medication injection pen having temperature sensor
US11931549B2 (en) 2017-12-12 2024-03-19 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US11918789B2 (en) 2017-12-12 2024-03-05 Bigfoot Biomedical, Inc. Therapy management systems, methods, and devices
US11904145B2 (en) 2017-12-12 2024-02-20 Bigfoot Biomedical, Inc. Diabetes therapy management systems, methods, and devices
US11154660B2 (en) 2017-12-12 2021-10-26 Bigfoot Biomedical, Inc. Diabetes therapy management systems, methods, and devices
US11896797B2 (en) 2017-12-12 2024-02-13 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11027073B2 (en) 2017-12-12 2021-06-08 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US11771835B2 (en) 2017-12-12 2023-10-03 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
US11090439B2 (en) 2017-12-12 2021-08-17 Bigfoot Biomedical, Inc. Therapy management systems, methods, and devices
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US20230108085A1 (en) * 2017-12-21 2023-04-06 Sanofi Determining a status of an injection
US11607501B2 (en) 2017-12-21 2023-03-21 Sanofi Acoustic detection of a usage of an injection device
CN111712283A (zh) * 2017-12-21 2020-09-25 赛诺菲 注射装置使用情况的声学检测
US11980747B2 (en) 2017-12-21 2024-05-14 Sanofi Acoustic detection of a usage of an injection device
US11878152B2 (en) * 2017-12-21 2024-01-23 Sanofi Determining a status of an injection
CN111712285A (zh) * 2017-12-21 2020-09-25 赛诺菲 确定注射状态
WO2019121612A1 (fr) * 2017-12-21 2019-06-27 Sanofi Détermination d'un état d'injection
US11559629B2 (en) * 2017-12-21 2023-01-24 Sanofi Determining a status of an injection
US20210077740A1 (en) * 2017-12-21 2021-03-18 Sanofi Determining a status of an injection
US11071831B2 (en) 2018-02-22 2021-07-27 Eli Lilly And Company Dose detection system module for medication delivery device
US11857770B2 (en) 2018-02-22 2024-01-02 Eli Lilly And Company Medication delivery device with a sensed element
US11590290B2 (en) 2018-03-08 2023-02-28 Robert Bosch Gmbh Drug delivery system
WO2019170429A1 (fr) * 2018-03-08 2019-09-12 Robert Bosch Gmbh Système d'administration de médicament
US20210085880A1 (en) * 2018-05-22 2021-03-25 Ypsomed Ag Click event identification in delivery devices
EA039524B1 (ru) * 2018-05-25 2022-02-07 Эли Лилли Энд Компани Устройство для доставки лекарственного препарата с измерительной системой
US11951285B2 (en) 2018-10-03 2024-04-09 Eli Lilly And Company Connected injection devices with status sensing systems
US11123488B2 (en) 2018-10-03 2021-09-21 Eli Lilly And Company Status sensing systems within an injection device assembly
USD1004078S1 (en) 2019-09-30 2023-11-07 Amgen Inc. Handheld drug delivery device
USD1010811S1 (en) 2019-09-30 2024-01-09 Amgen Inc. Handheld drug delivery device
USD1030040S1 (en) 2020-01-14 2024-06-04 Amgen Inc. Handheld drug delivery device
USD1030041S1 (en) 2020-01-14 2024-06-04 Amgen Inc. Handheld drug delivery device
WO2021219460A1 (fr) * 2020-04-29 2021-11-04 Shl Medical Ag Dispositif concentrateur pour un dispositif médical portatif
USD1010107S1 (en) 2020-11-05 2024-01-02 Amgen Inc. Handheld drug delivery device
USD992109S1 (en) 2020-11-05 2023-07-11 Amgen Inc. Handheld drug delivery device
USD990668S1 (en) 2020-11-05 2023-06-27 Amgen Inc. Handheld drug delivery device
USD985118S1 (en) 2021-03-10 2023-05-02 Amgen Inc. Handheld drug delivery device
USD985116S1 (en) 2021-03-10 2023-05-02 Amgen Inc. Handheld drug delivery device
USD985117S1 (en) 2021-03-10 2023-05-02 Amgen Inc. Handheld drug delivery device
USD985119S1 (en) 2021-03-30 2023-05-02 Amgen Inc. Handheld drug delivery device
USD1048382S1 (en) 2024-03-08 2024-10-22 Amgen Inc. Autoinjector with removable cap

Also Published As

Publication number Publication date
EP2911717A4 (fr) 2016-06-15
EP2911717B1 (fr) 2019-05-22
US10842943B2 (en) 2020-11-24
WO2014064691A3 (fr) 2014-07-03
US20190192779A1 (en) 2019-06-27
WO2014064691A2 (fr) 2014-05-01
EP2911717A2 (fr) 2015-09-02

Similar Documents

Publication Publication Date Title
US10842943B2 (en) Drug dispensing-tracking device, system and method
US10569028B2 (en) Drug tracking device
US10016565B2 (en) Medical assembly with monitoring device
CN110325954B (zh) 用于使用特定于hcp的装置进行患者监测的系统和方法
JP2020179187A (ja) 薬剤搬送デバイスを増強するための方法および装置
EP3188061B1 (fr) Dispositif auxiliaire et système pour un injecteur permettant de surveiller des quantités injectées
RU2459247C2 (ru) Электронный модуль для механического устройства введения лекарственных средств
US10460836B2 (en) Medical device system and method for establishing wireless communication
JP6518231B2 (ja) 医療デバイスデータ処理方法及びシステム、並びに医療デバイスデータ通信方法及びシステム
EP2810676A1 (fr) Dispositif de suivi à distance d'au moins un dispositif médical
WO2016160344A1 (fr) Dispositif d'évaluation de la mobilité d'un patient
CN108475479B (zh) 药物训练装置和系统
JP2020501858A (ja) 薬剤投与機器のためのイベント記録装置
KR102624388B1 (ko) 개선된 준수를 위해 자동 주사기 사용을 디지털 방식으로 모니터링하기 위한 기기 부속품, 원격 환자 모니터링, 및 처방 준수
KR20160094401A (ko) 의료 장치 연결 스테이션
FR2868323B1 (fr) Dispositif medical implantable actif pourvu de moyens de diagnostic de troubles respiratoires, a detection perfectionnee des cycles respiratoires artefactes
KR20160134715A (ko) 혈당측정기 및 사용 방법
WO2024177976A1 (fr) Architecture électromécanique pour seringues jetables pré-remplies connectées
TW202238611A (zh) 藥物依從性系統
US20180340902A1 (en) Measuring device for blood and/or liquid interstitial analytes

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

AS Assignment

Owner name: INSULINE MEDICAL LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAGAR, RON;BITTON, GABRIEL;FADLUN, MOSHE;SIGNING DATES FROM 20190224 TO 20190227;REEL/FRAME:048472/0845

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION